Weight-Loss Drug Wegovy Slashes Risk of Death in Some People with Heart Disease
Briefly

from www.scientificamerican.com5 months ago
Semaglutide, a drug used to treat diabetes and aid weight loss, has been found to lower the risk of heart attack, stroke, and death from cardiovascular disease by 20%.
www.scientificamerican.comhttps://www.scientificamerican.com/article/weight-loss-drug-wegovy-slashes-risk-of-death-in-some-people-with-heart-disease/
The drug works by regulating appetite hormones and causing people to feel full longer, leading to weight loss and reduced cardiovascular risk
www.scientificamerican.comhttps://www.scientificamerican.com/article/weight-loss-drug-wegovy-slashes-risk-of-death-in-some-people-with-heart-disease/
People who took the drug lost a significant amount of weight, thus reducing their risk of cardiac complications, but experts say that the amount of improvement suggests the drug's heart effects likely occurred through mechanisms besides weight loss alone.
www.scientificamerican.comhttps://www.scientificamerican.com/article/weight-loss-drug-wegovy-slashes-risk-of-death-in-some-people-with-heart-disease/
Physicians are excited to potentially have a new way of reducing cardiovascular risk in certain people, although their enthusiasm is somewhat tempered by the cost of the drug and its side effects.
www.scientificamerican.comhttps://www.scientificamerican.com/article/weight-loss-drug-wegovy-slashes-risk-of-death-in-some-people-with-heart-disease/
Scientific American spoke with Massachusetts General Hospital cardiologist James Januzzi, who was not involved in the study, about how we should view its new findings.
www.scientificamerican.comhttps://www.scientificamerican.com/article/weight-loss-drug-wegovy-slashes-risk-of-death-in-some-people-with-heart-disease/
Read at www.scientificamerican.com
[
add
]
[
|
|
]